查看購物車
  • Simplified Chinese
  • English
北美近視治療市場預測至 2030 年 - 區域分析 - 按類型、治療、年齡層和最終用戶
市場調查報告書
商品編碼
1562242

北美近視治療市場預測至 2030 年 - 區域分析 - 按類型、治療、年齡層和最終用戶

North America Myopia Treatment Market Forecast to 2030 - Regional Analysis - by Type, Treatment, Age Group, and End User
出版日期: | 出版商: The Insight Partners | 英文 109 Pages | 訂單完成後即時交付

價格

2022年北美近視治療市值為39.389億美元，預計到2030年將達到73.3526億美元；預計2022年至2030年複合年成長率為8.1%。

近視盛行率上升推動北美近視治療市場

全球近視盛行率不斷上升，是一個重大的公共衛生問題，尤其是兒童和年輕人的近視發病率不斷上升。最近的一項研究估計，到 2050 年，世界上近 50% 的人口（即 50 億人）將患有近視，高於目前 30% 的平均水平。在美國，近視發生率也在增加；據報道，這一比例為 42%，在短短 30 年內幾乎加倍。多種因素促成了這一趨勢，包括生活方式的改變、城市化進程的加快以及大量的近距離工作活動，例如長時間使用數位設備和有限的戶外活動。雖然遺傳傾向發揮一定作用，但環境因素也會導致近視率大幅上升。這些生活方式和環境因素的影響使人們更加了解遺傳易感性和環境影響之間複雜的相互作用，進一步強調需要採取全面的策略來解決這個新興的公共衛生問題。隨著近視盛行率持續上升，人們越來越重視制定積極的干涉措施、公共衛生運動和創新治療方法，以減輕高度近視及其相關眼部併發症的長期影響，從而強調解決這一問題的重要性多方面的全球健康挑戰。

北美近視治療市場概況

北美近視治療市場已細分為美國、加拿大和墨西哥。美國佔據北美近視治療市場的最大佔有率。美國市場的成長將歸因於諸如近視相關視力喪失發生率的增加以及未經治療的近視導致遠視力損害的發生率上升等因素。此外，政府對眼睛健康和技術進步的支持不斷增加是推動北美市場成長的重要因素。

美國近視治療市場預計在未來幾年將顯著成長。近年來，近視盛行率不斷增加，這推動了對有效治療的需求。根據近視研究所 2023 年發布的資料，美國的盛行率為 42%，在短短三十年中幾乎加倍。例如，布萊恩霍爾頓視力研究所 (Brien Holden Vision Institute) 的 2024 年近視意識週選擇了《近視管理回顧》(Review of Myopia Management) 作為其官方聯合贊助商。此次合作將有助於擴大近視宣傳週的影響範圍，該活動定於2024 年5 月13 日至19 日在國內和國際舉行。患其他眼部疾病的風險增加-白內障和青光眼。這導致有助於預防或減緩近視進展的有效治療的需求更大。推動美國近視治療市場成長的另一個因素是先進技術和治療方法的可用性。現在有多種近視治療方法，包括矯正鏡片、角膜塑身術和藥物治療。這些治療方法變得越來越複雜和有效，有助於推動近視治療的需求。最後，兒童近視盛行率的不斷上升也推動了美國近視治療市場的成長。隨著越來越多的兒童被診斷出患有近視，更需要有效的治療方法來幫助預防或減緩其發展。這導致了對專門為兒童設計的新療法的研究和開發的投資增加。總體而言，隨著越來越多的人意識到這種情況以及對有效治療的需求增加，美國近視治療市場預計在未來幾年將會成長。

北美近視治療市場收入及 2030 年預測（百萬美元）

北美近視治療市場細分

北美近視治療市場按類型、治療、年齡層、最終用戶和國家分類。

根據類型，北美近視治療市場分為高度近視、退化性近視和進行性近視。 2022 年，高度近視細分市場佔據北美近視治療市場最大佔有率。

在治療方面，北美近視治療市場分為低劑量阿托品眼藥水、隱形眼鏡、角膜塑形鏡和屈光手術。 2022年，低劑量阿托品眼藥水細分市場佔據北美近視治療市場最大佔有率。

依年齡層別分類，北美近視治療市場分為成人近視和兒童近視。 2022 年，成人近視細分市場將佔據更大的北美近視治療市場。

根據最終用戶，北美近視治療市場分為醫院和診所、專科診所和屈光手術中心。 2022 年，醫院和診所細分市場佔據北美近視治療市場最大佔有率。

依國家分類，北美近視治療市場分為美國、加拿大和墨西哥。 2022年，美國在北美近視治療市場佔有率中佔據主導地位。

Bausch Health Companies Inc、Alcon AG、CooperVision Inc、Johnson & Johnson Vision Care Inc、Topcon Healthcare Solutions Inc、Ziemer Ophthalmic Systems AG、Nidek Co Ltd、Eyes Vision SL、Haag-Streit AG 和 Carl Zeiss AG。是北美近視治療市場上的一些領先公司。

目錄

第 1 章：簡介

第 2 章：執行摘要

  • 主要見解

第 3 章：研究方法

  • 覆蓋範圍
  • 二次研究
  • 初步研究

第 4 章：北美近視治療市場格局

  • 概述
  • PEST分析
  • 按公司分類的市佔率分析

第 5 章：北美近視治療市場 - 主要市場動態

  • 北美近視治療市場 - 主要市場動態
  • 市場促進因素
    • 近視盛行率上升
    • 提高近視治療意識
  • 市場限制
    • 缺乏熟練的專業人員
  • 市場機會
    • 用於治療目標近視的先進技術的可用性不斷提高
  • 未來趨勢
    • 人工智慧在近視治療的應用
  • 促進因素和限制的影響：

第 6 章：近視治療市場 - 北美市場分析

第 7 章：北美近視治療市場分析 - 按類型

  • 高度近視
  • 退化性近視
  • 進行性近視

第 8 章：北美近視治療市場分析 - 按治療分類

  • 小劑量阿托品眼藥水
  • 屈光手術
  • 隱形眼鏡
  • 骨科矯形術

第 9 章：北美近視治療市場分析 - 按年齡層

  • 成人近視
  • 兒童近視

第 10 章：北美近視治療市場分析 - 按最終用戶

  • 醫院和診所
  • 專科診所
  • 屈光手術中心

第 11 章：北美近視治療市場 - 國家分析

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥

第 12 章：產業格局

  • 概述
  • 近視治療市場的成長策略
  • 有機成長策略
    • 概述
  • 無機成長策略
    • 概述

第 13 章：公司簡介

  • Bausch Health Companies Inc
  • Alcon AG
  • CooperVision Inc
  • Johnson & Johnson Vision Care Inc
  • Topcon Healthcare Solutions Inc
  • Ziemer Ophthalmic Systems AG
  • Nidek Co Ltd
  • Eyes Vision SL
  • Haag-Streit AG
  • Carl Zeiss AG

第 14 章：附錄

Product Code: BMIRE00030510

The North America myopia treatment market was valued at US$ 3,938.90 million in 2022 and is expected to reach US$ 7,335.26 million by 2030; it is estimated to register a CAGR of 8.1% from 2022 to 2030.

Rising Prevalence of Myopia Fuels North America Myopia Treatment Market

The rising prevalence of myopia globally represents a significant public health concern, with increasing incidences observed among children and young adults, particularly. A recent study estimated that by 2050, nearly 50% of the world's population-or 5 billion people-will be myopic, up from the current average of 30%. The frequency of myopia is also increasing in the US; it has been reported to be 42%, nearly doubling in just three decades. Multiple factors contribute to this trend, including lifestyle changes, increased urbanization, and extensive near-work activities, such as prolonged use of digital devices and limited outdoor exposure. While genetic predisposition plays a role, environmental factors also contribute to escalating the rates of myopia substantially. The impact of these lifestyle and environmental factors has led to an enhanced understanding of the complex interplay between genetic susceptibility and environmental influences, further underscoring the need for comprehensive strategies to address this burgeoning public health issue. As the prevalence of myopia continues to rise, there is a growing emphasis on developing proactive interventions, public health campaigns, and innovative treatment approaches to mitigate the long-term implications of high myopia and its associated ocular complications, thereby emphasizing the importance of addressing this multifaceted global health challenge.

North America Myopia Treatment Market Overview

The North America myopia treatment market has been segmented into the US, Canada, and Mexico. The US holds the largest share of the North America myopia treatment market. The market growth in the US will be due to factors such as the growing myopia-related occurrences of vision loss and rising incidence of distant vision impairment from untreated myopia. Furthermore, the rising government support for eye health and technological advancements are prominent factors propelling the North America market growth.

The US myopia treatment market is expected to experience significant growth in the coming years. The prevalence of myopia has been increasing in recent years, which is driving the demand for effective treatments. The US has reported a prevalence of 42%, nearly doubling in just three decades, according to data released by the Myopia Institute in 2023. Furthermore, increasing awareness about myopia is also driving market growth. For instance, the Brien Holden Vision Institute's 2024 Myopia Awareness Week has selected Review of Myopia Management as its official co-sponsor. The collaboration will assist in expanding the reach of Myopia Awareness Week, which is scheduled for domestically and internationally, May 13-19, 2024. More people are becoming aware of the risks associated with myopia, such as an increased risk of developing other eye conditions-cataracts and glaucoma. This has led to a greater demand for effective treatments that can help prevent or slow down the progression of myopia. Another factor driving the growth of the myopia treatment market in the US is the availability of advanced technologies and treatments. Various treatments for myopia are now available, including corrective lenses, orthokeratology, and pharmacological treatments. These treatments are becoming increasingly sophisticated and effective, helping drive demand for myopia treatment. Finally, the growing prevalence of myopia among children is also driving the growth of the myopia treatment market in the US. As more children are diagnosed with myopia, there is a greater need for effective treatments that can help prevent or slow down its progression. This has led to increased investment in research and development of new treatments specifically designed for children. Overall, the US myopia treatment market is expected to grow in the coming years as more people become aware of the condition and demand for effective treatments increases.

North America Myopia Treatment Market Revenue and Forecast to 2030 (US$ Million)

North America Myopia Treatment Market Segmentation

The North America myopia treatment market is categorized into type, treatment, age group, end user, and country.

Based on type, the North America myopia treatment market is segmented into high myopia, degenerative myopia, and progressive myopia. The high myopia segment held the largest North America myopia treatment market share in 2022.

In terms of treatment, the North America myopia treatment market is segmented into low-dose atropine eye drops, contact lenses, ortho-k, and refractive surgery. The low-dose atropine eye drops segment held the largest North America myopia treatment market share in 2022. Furthermore, the refractive surgery segment is subcategorized into LASIK and PRK.

By age group, the North America myopia treatment market is bifurcated into adult myopia and childhood myopia. The adult myopia segment held a larger North America myopia treatment market share in 2022.

Based on end user, the North America myopia treatment market is categorized into hospitals and clinics, specialty clinics, and refractive surgery centers. The hospitals and clinics segment held the largest North America myopia treatment market share in 2022.

Based on country, the North America myopia treatment market is categorized into the US, Canada, and Mexico. The US dominated the North America myopia treatment market share in 2022.

Bausch Health Companies Inc, Alcon AG, CooperVision Inc, Johnson & Johnson Vision Care Inc, Topcon Healthcare Solutions Inc, Ziemer Ophthalmic Systems AG, Nidek Co Ltd, Eyes Vision SL, Haag-Streit AG, and Carl Zeiss AG. are some of the leading companies operating in the North America myopia treatment market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. North America Myopia Treatment Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
  • 4.3 Market Share Analysis, By Companies

5. North America Myopia Treatment Market - Key Market Dynamics

  • 5.1 North America Myopia Treatment Market - Key Market Dynamics
  • 5.2 Market Drivers
    • 5.2.1 Rising Prevalence of Myopia
    • 5.2.2 Increased Awareness of Myopia Treatment
  • 5.3 Market Restraints
    • 5.3.1 Lack of Skilled Professionals
  • 5.4 Market Opportunities
    • 5.4.1 Rising Availability of Advanced Technologies for Treating the Targeted Myopia
  • 5.5 Future Trends
    • 5.5.1 Application of Artificial Intelligence in Myopia Treatment
  • 5.6 Impact of Drivers and Restraints:

6. Myopia Treatment Market - North America Market Analysis

7. North America Myopia Treatment Market Analysis - by Type

  • 7.1 High Myopia
    • 7.1.1 Overview
    • 7.1.2 High Myopia: North America Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.2 Degenerative Myopia
    • 7.2.1 Overview
    • 7.2.2 Degenerative Myopia: North America Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.3 Progressive Myopia
    • 7.3.1 Overview
    • 7.3.2 Progressive Myopia: North America Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)

8. North America Myopia Treatment Market Analysis - by Treatment

  • 8.1 Low-Dose Atropine Eye Drops
    • 8.1.1 Overview
    • 8.1.2 Low-Dose Atropine Eye Drops: North America Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.2 Refractive Surgery
    • 8.2.1 Overview
    • 8.2.2 Refractive Surgery: North America Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
    • 8.2.3 LASIK
    • 8.2.4 PRK
  • 8.3 Contact Lenses
    • 8.3.1 Overview
    • 8.3.2 Contact Lenses: North America Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Ortho-K
    • 8.4.1 Overview
    • 8.4.2 Ortho-K: North America Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)

9. North America Myopia Treatment Market Analysis - by Age Group

  • 9.1 Adult Myopia
    • 9.1.1 Overview
    • 9.1.2 Adult Myopia: North America Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.2 Childhood Myopia
    • 9.2.1 Overview
    • 9.2.2 Childhood Myopia: North America Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)

10. North America Myopia Treatment Market Analysis - by End User

  • 10.1 Hospitals and Clinics
    • 10.1.1 Overview
    • 10.1.2 Hospitals and Clinics: North America Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • 10.2 Specialty Clinics
    • 10.2.1 Overview
    • 10.2.2 Specialty Clinics: North America Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • 10.3 Refractive Surgery Centers
    • 10.3.1 Overview
    • 10.3.2 Refractive Surgery Centers: North America Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)

11. North America Myopia Treatment Market - Country Analysis

  • 11.1 North America
    • 11.1.1 North America Myopia Treatment Market
    • 11.1.2 North America: Myopia Treatment Market - Revenue and Forecast Analysis - by Country
      • 11.1.2.1 North America: Myopia Treatment Market - Revenue and Forecast Analysis - by Country
      • 11.1.2.2 US
      • 11.1.2.3 US: Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.1.2.3.1 US: Myopia Treatment Market Breakdown, by Type
        • 11.1.2.3.2 US: Myopia Treatment Market Breakdown, by Treatment
        • 11.1.2.3.3 US: Myopia Treatment Market Breakdown, by Refractive Surgery
        • 11.1.2.3.4 US: Myopia Treatment Market Breakdown, by Age Group
        • 11.1.2.3.5 US: Myopia Treatment Market Breakdown, by End User
      • 11.1.2.4 Canada
      • 11.1.2.5 Canada: Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.1.2.5.1 Canada: Myopia Treatment Market Breakdown, by Type
        • 11.1.2.5.2 Canada: Myopia Treatment Market Breakdown, by Treatment
        • 11.1.2.5.3 Canada: Myopia Treatment Market Breakdown, by Refractive Surgery
        • 11.1.2.5.4 Canada: Myopia Treatment Market Breakdown, by Age Group
        • 11.1.2.5.5 Canada: Myopia Treatment Market Breakdown, by End User
      • 11.1.2.6 Mexico
      • 11.1.2.7 Mexico: Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.1.2.7.1 Mexico: Myopia Treatment Market Breakdown, by Type
        • 11.1.2.7.2 Mexico: Myopia Treatment Market Breakdown, by Treatment
        • 11.1.2.7.3 Mexico: Myopia Treatment Market Breakdown, by Refractive Surgery
        • 11.1.2.7.4 Mexico: Myopia Treatment Market Breakdown, by Age Group
        • 11.1.2.7.5 Mexico: Myopia Treatment Market Breakdown, by End User

12. Industry Landscape

  • 12.1 Overview
  • 12.2 Growth Strategies in Myopia Treatment Market
  • 12.3 Organic Growth Strategies
    • 12.3.1 Overview
  • 12.4 Inorganic Growth Strategies
    • 12.4.1 Overview

13. Company Profiles

  • 13.1 Bausch Health Companies Inc
    • 13.1.1 Key Facts
    • 13.1.2 Business Description
    • 13.1.3 Products and Services
    • 13.1.4 Financial Overview
    • 13.1.5 SWOT Analysis
    • 13.1.6 Key Developments
  • 13.2 Alcon AG
    • 13.2.1 Key Facts
    • 13.2.2 Business Description
    • 13.2.3 Products and Services
    • 13.2.4 Financial Overview
    • 13.2.5 SWOT Analysis
    • 13.2.6 Key Developments
  • 13.3 CooperVision Inc
    • 13.3.1 Key Facts
    • 13.3.2 Business Description
    • 13.3.3 Products and Services
    • 13.3.4 Financial Overview
    • 13.3.5 SWOT Analysis
    • 13.3.6 Key Developments
  • 13.4 Johnson & Johnson Vision Care Inc
    • 13.4.1 Key Facts
    • 13.4.2 Business Description
    • 13.4.3 Products and Services
    • 13.4.4 Financial Overview
    • 13.4.5 SWOT Analysis
    • 13.4.6 Key Developments
  • 13.5 Topcon Healthcare Solutions Inc
    • 13.5.1 Key Facts
    • 13.5.2 Business Description
    • 13.5.3 Products and Services
    • 13.5.4 Financial Overview
    • 13.5.5 SWOT Analysis
    • 13.5.6 Key Developments
  • 13.6 Ziemer Ophthalmic Systems AG
    • 13.6.1 Key Facts
    • 13.6.2 Business Description
    • 13.6.3 Products and Services
    • 13.6.4 Financial Overview
    • 13.6.5 SWOT Analysis
    • 13.6.6 Key Developments
  • 13.7 Nidek Co Ltd
    • 13.7.1 Key Facts
    • 13.7.2 Business Description
    • 13.7.3 Products and Services
    • 13.7.4 Financial Overview
    • 13.7.5 SWOT Analysis
    • 13.7.6 Key Developments
  • 13.8 Eyes Vision SL
    • 13.8.1 Key Facts
    • 13.8.2 Business Description
    • 13.8.3 Products and Services
    • 13.8.4 Financial Overview
    • 13.8.5 SWOT Analysis
    • 13.8.6 Key Developments
  • 13.9 Haag-Streit AG
    • 13.9.1 Key Facts
    • 13.9.2 Business Description
    • 13.9.3 Products and Services
    • 13.9.4 Financial Overview
    • 13.9.5 SWOT Analysis
    • 13.9.6 Key Developments
  • 13.10 Carl Zeiss AG
    • 13.10.1 Key Facts
    • 13.10.2 Business Description
    • 13.10.3 Products and Services
    • 13.10.4 Financial Overview
    • 13.10.5 SWOT Analysis
    • 13.10.6 Key Developments

14. Appendix

  • 14.1 About The Insight Partners
  • 14.2 Glossary of Terms

List Of Tables

  • Table 1. North America Myopia Treatment Market Segmentation
  • Table 2. Market Share (~) by Companies in the Global Myopia Treatment Market (%)
  • Table 3. North America Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by Type
  • Table 4. North America Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by Treatment
  • Table 5. North America Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by Age Group
  • Table 6. North America Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by End User
  • Table 7. North America: Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by Country
  • Table 8. US: Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by Type
  • Table 9. US: Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by Treatment
  • Table 10. US: Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by Refractive Surgery
  • Table 11. US: Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by Age Group
  • Table 12. US: Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by End User
  • Table 13. Canada: Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by Type
  • Table 14. Canada: Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by Treatment
  • Table 15. Canada: Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by Refractive Surgery
  • Table 16. Canada: Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by Age Group
  • Table 17. Canada: Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by End User
  • Table 18. Mexico: Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by Type
  • Table 19. Mexico: Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by Treatment
  • Table 20. Mexico: Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by Refractive Surgery
  • Table 21. Mexico: Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by Age Group
  • Table 22. Mexico: Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by End User
  • Table 23. Recent Organic Growth Strategies in Myopia Treatment Market
  • Table 24. Recent Inorganic Growth Strategies in the Myopia Treatment Market
  • Table 25. Glossary of Terms, Myopia Treatment Market

List Of Figures

  • Figure 1. North America Myopia Treatment Market Segmentation, by Country
  • Figure 2. PEST Analysis
  • Figure 3. Impact Analysis of Drivers and Restraints
  • Figure 4. North America Myopia Treatment Market Revenue (US$ Million), 2022-2030
  • Figure 5. North America Myopia Treatment Market Share (%) - by Type (2022 and 2030)
  • Figure 6. High Myopia: North America Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 7. Degenerative Myopia: North America Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 8. Progressive Myopia: North America Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 9. North America Myopia Treatment Market Share (%) - by Treatment (2022 and 2030)
  • Figure 10. Low-Dose Atropine Eye Drops: North America Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 11. Refractive Surgery: North America Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 12. LASIK: North America Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 13. PRK: North America Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. Contact Lenses: North America Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 15. Ortho-K: North America Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 16. North America Myopia Treatment Market Share (%) - by Age Group (2022 and 2030)
  • Figure 17. Adult Myopia: North America Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. Childhood Myopia: North America Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 19. North America Myopia Treatment Market Share (%) - by End User (2022 and 2030)
  • Figure 20. Hospitals and Clinics: North America Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 21. Specialty Clinics: North America Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 22. Refractive Surgery Centers: North America Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 23. North America: Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 24. North America: Myopia Treatment Market Breakdown, by Key Countries, 2022 and 2030 (%)
  • Figure 25. US: Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 26. Canada: Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 27. Mexico: Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 28. Growth Strategies in Myopia Treatment Market